ABVC BIOPHARMA, INC.
Can this company survive a downturn?
How efficiently does it turn assets into profit?
Is the business becoming more valuable over time?
1.1. Financial Health of ABVC BIOPHARMA, INC. (5 min.)
π€ Analyze $ABVC using your own AI
Download Penkeβs AI-structured dataset for ABVC BIOPHARMA, INC..
Ask your own questions, run scenarios, and test assumptions in the AI you already use.
Your edge in this era:
π₯Έ Penkeβs data + π€ AI + π§ YOUR judgment.
You can use the AI prompts per pain point I prepared to guide your analysis.
Want to see how it works first? Start with a real example:
π₯ Download example dataset ($NVDA)* I continuously improve the AI structure.
If something feels unclear or incomplete, email me or message me on Discord.
β Iβll fix it. π₯Έ Penke
Key Takeaways
What matters most right now.
β Cash generation
Free cash flow of $0.0B equals a -196.9% margin, broadly in line with its 5-year average of -278.8%, indicating stable cash generation.
β Financial resilience
The company has a current ratio of 0.63, compared to a 5-year average of 0.39. This shows how well it can cover short-term obligations if conditions worsen.
β Debt levels
Debt relative to equity is 0.55, compared to a 5-year average of 2.46. This shows whether leverage is increasing or staying disciplined.
β οΈ Share dilution
Shares outstanding increased by 40.35% year-over-year, which slightly reduces each shareholderβs ownership.
β οΈ Capital efficiency
Return on equity is -10.7%, compared to a 5-year average of 78.2%. This shows how effectively management turns shareholder capital into profit.
Why this matters
The facts behind the takeaways.
β How much profit the business keeps
The company keeps -146.8% profit from its sales. Over the past 5 years, this was about -382.6%.
β How much cash the business generates
About -196.9% of sales turns into real cash. Historically, this was closer to -278.8%.
β Ability to pay short-term bills
The companyβs short-term financial buffer is 0.63, compared to 0.39 historically.
β Debt pressure
Debt levels are 0.55 today, compared to 2.46 over the last 5 years.
What to watch next
Focus points for the next quarters.
β Next earnings
Watch whether revenue growth translates into sustained margin improvement next quarter.
Balance Sheet
Showing financial position from 2010-06-30 to 2025-09-30.
Income Statement
Performance overview from 2010-06-30 to 2025-09-30.
Cash Flow Statement
Operational cash dynamics from 2010-06-30 to 2025-09-30.